Cargando…

A Live Salmonella Vaccine Delivering PcrV through the Type III Secretion System Protects against Pseudomonas aeruginosa

Pseudomonas aeruginosa is a common Gram-negative opportunistic pathogen that is intrinsically resistant to a wide range of antibiotics. The development of a broadly protective vaccine against P. aeruginosa remains a major challenge. Here, we used an attenuated strain of Salmonella enterica serovar T...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aguilera-Herce, Julia, García-Quintanilla, Meritxell, Romero-Flores, Rocío, McConnell, Michael J., Ramos-Morales, Francisco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6470209/ https://www.ncbi.nlm.nih.gov/pubmed/30996108 http://dx.doi.org/10.1128/mSphere.00116-19

Ejemplares similares

Identification of Small Molecules Blocking the Pseudomonas aeruginosa Type III Secretion System Protein PcrV
por: Sundin, Charlotta, et al.
Publicado: (2021)

PopB-PcrV Interactions Are Essential for Pore Formation in the Pseudomonas aeruginosa Type III Secretion System Translocon
por: Kundracik, Emma, et al.
Publicado: (2022)

Modified Needle-Tip PcrV Proteins Reveal Distinct Phenotypes Relevant to the Control of Type III Secretion and Intoxication by Pseudomonas aeruginosa
por: Sato, Hiromi, et al.
Publicado: (2011)

Type III secretion proteins PcrV and PcrG from Pseudomonas aeruginosa form a 1:1 complex through high affinity interactions
por: Nanao, Max, et al.
Publicado: (2003)

Type III Secretion Protein, PcrV, Impairs Pseudomonas aeruginosa Biofilm Formation by Increasing M1 Macrophage-Mediated Anti-bacterial Activities
por: Yu, Hua, et al.
Publicado: (2020)

Rational Design of a Chimeric Derivative of PcrV as a Subunit Vaccine Against Pseudomonas aeruginosa
por: Wan, Chuang, et al.
Publicado: (2019)

Self-assembled ferritin nanoparticles displaying PcrV and OprI as an adjuvant-free Pseudomonas aeruginosa vaccine
por: Li, Yuhang, et al.
Publicado: (2023)

Multi-Functional Characteristics of the Pseudomonas aeruginosa Type III Needle-Tip Protein, PcrV; Comparison to Orthologs in other Gram-negative Bacteria
por: Sato, Hiromi, et al.
Publicado: (2011)

Effects of monoclonal anti-PcrV antibody on Pseudomonas aeruginosa-induced acute lung injury in a rat model
por: Faure, Karine, et al.
Publicado: (2003)

Production of an Antibody Fragment (scFv) Targeting PcrV Protein of Pseudomonas aeruginosa in Fed-Batch Cultivation Mode
por: Karam, Saba, et al.
Publicado: (2021)

Vaccination of mice with hybrid protein containing Exotoxin S and PcrV with adjuvants alum and MPL protects Pseudomonas aeruginosa infections
por: Asadi Karam, Mohammad Reza, et al.
Publicado: (2022)

Protective Effect of DNA Vaccine Encoding Pseudomonas Exotoxin A and PcrV against Acute Pulmonary P. aeruginosa Infection
por: Jiang, Mingzi, et al.
Publicado: (2014)

Development of a Chimeric Vaccine Against Pseudomonas aeruginosa Based on the Th17-Stimulating Epitopes of PcrV and AmpC
por: Wang, Ying, et al.
Publicado: (2021)

Strong immune responses and protection of PcrV and OprF-I mRNA vaccine candidates against Pseudomonas aeruginosa
por: Wang, Xingyun, et al.
Publicado: (2023)

Protective Efficacy of the Trivalent Pseudomonas aeruginosa Vaccine Candidate PcrV-OprI-Hcp1 in Murine Pneumonia and Burn Models
por: Yang, Feng, et al.
Publicado: (2017)

Protective Efficacy of the OprF/OprI/PcrV Recombinant Chimeric Protein Against Pseudomonas aeruginosa in the Burned BALB/c Mouse Model
por: Fakoor, Mohammad Hadi, et al.
Publicado: (2020)

Outer Membrane Vesicles Displaying a Heterologous PcrV-HitA Fusion Antigen Promote Protection against Pulmonary Pseudomonas aeruginosa Infection
por: Li, Peng, et al.
Publicado: (2021)

697. Pseudomonas aeruginosa PcrV and Psl, the Molecular Targets of Bispecific Monoclonal Antibody MEDI3902, Are Conserved Among Diverse Hospital Isolates Collected From an International Surveillance Study
por: Tabor, David E
Publicado: (2018)

Salmonella Type III Secretion Effector SrfJ: A Glucosylceramidase Affecting the Lipidome and the Transcriptome of Mammalian Host Cells
por: Aguilera-Herce, Julia, et al.
Publicado: (2023)

Structure and Function of the Type III Secretion System of Pseudomonas aeruginosa
por: Galle, Marlies, et al.
Publicado: (2012)

Bacteriophage–Antibiotic Combination Therapy against Pseudomonas aeruginosa
por: Santamaría-Corral, Guillermo, et al.
Publicado: (2023)

Modulation of the immune response by the Pseudomonas aeruginosa type-III secretion system
por: Jouault, Albane, et al.
Publicado: (2022)

Pseudomonas aeruginosa PcrV Enhances the Nitric Oxide-Mediated Tumoricidal Activity of Tumor-Associated Macrophages via a TLR4/PI3K/AKT/mTOR-Glycolysis-Nitric Oxide Circuit
por: Yu, Hua, et al.
Publicado: (2021)

Characterization of a novel mCH3 conjugated anti-PcrV scFv molecule
por: Komijani, Samira, et al.
Publicado: (2021)

PcrG protects the two long helical oligomerization domains of PcrV, by an interaction mediated by the intramolecular coiled-coil region of PcrG
por: Basu, Abhishek, et al.
Publicado: (2014)

Intrinsic and Extrinsic Regulation of Type III Secretion Gene Expression in Pseudomonas Aeruginosa
por: Diaz, Manisha R., et al.
Publicado: (2011)

Glutathione Activates Type III Secretion System Through Vfr in Pseudomonas aeruginosa
por: Zhang, Yani, et al.
Publicado: (2019)

The role of Type III secretion system in the pathogenesis of Pseudomonas aeruginosa microbial keratitis
por: Yang, Justin J., et al.
Publicado: (2021)

Type III Secretion of ExoU Is Critical during Early Pseudomonas aeruginosa Pneumonia
por: Howell, Heather A., et al.
Publicado: (2013)

Calcium Chelation by Alginate Activates the Type III Secretion System in Mucoid Pseudomonas aeruginosa Biofilms
por: Horsman, Shawn R., et al.
Publicado: (2012)

Diversity of Virulence Phenotypes among Type III Secretion Negative Pseudomonas aeruginosa Clinical Isolates
por: Toska, Jonida, et al.
Publicado: (2014)

Modulation of Type III Secretion System in Pseudomonas aeruginosa: Involvement of the PA4857 Gene Product
por: Zhu, Miao, et al.
Publicado: (2016)

Novel Type III Effectors in Pseudomonas aeruginosa
por: Burstein, David, et al.
Publicado: (2015)

Structural Basis of Cytotoxicity Mediated by the Type III Secretion Toxin ExoU from Pseudomonas aeruginosa
por: Gendrin, Claire, et al.
Publicado: (2012)

Corrigendum: Modulation of Type III Secretion System in Pseudomonas aeruginosa: Involvement of the PA4857 Gene Product
por: Zhu, Miao, et al.
Publicado: (2016)

Association between Pseudomonas aeruginosa type III secretion, antibiotic resistance, and clinical outcome: a review
por: Sawa, Teiji, et al.
Publicado: (2014)

Design and characterization of a polyamine derivative inhibiting the expression of type III secretion system in Pseudomonas aeruginosa
por: Wang, Chao, et al.
Publicado: (2016)

Fitness Cost of Fluoroquinolone Resistance in Clinical Isolates of Pseudomonas aeruginosa Differs by Type III Secretion Genotype
por: Agnello, Melissa, et al.
Publicado: (2016)

Pseudomonas aeruginosa Type III Secretion System Virulotypes and Their Association with Clinical Features of Cystic Fibrosis Patients
por: Sarges, Edilene do Socorro Nascimento Falcão, et al.
Publicado: (2020)

MvaT binds to the P (exsC) promoter to repress the type III secretion system in Pseudomonas aeruginosa
por: Yin, Liwen, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_dh1q490o4q2kot3t92v5smrlu9